1-3 of 3
Stephane Prost
Close
Sort by
Journal Articles

Erosion Of The Chronic Myeloid Leukemia Stem Cell Pool By PPARγ Agonists

Stephane Prost, Francis Relouzat, Marc Spenchian, Gérald Massonnet, Jean-Paul Beressi, Els Verhoeyen, Benjamin Maneglier, Sylvie Castaigne, Christine Chomienne, Stany Chretien, Philippe Rousselot, Philippe Leboulch, PhD
Journal: Blood
Blood (2013) 122 (21): 5197.
https://doi.org/10.1182/blood.V122.21.5197.5197
Published: 2013
Journal Articles

Loss Of Major Molecular Response As a Trigger For Restarting Tyrosine Kinase Inhibitor Therapy In CP-CML Patients Who Have Stopped Imatinib After Durable Undetectable Minimal Residual Disease

Philippe Rousselot, Aude Charbonnier, Pascale Cony-Makhoul, Philippe Agape, Franck E Nicolini, MD, PhD, Bruno R. Varet, MD, Martine Gardembas, Gabriel Etienne, Delphine Rea, Lydia Roy, Martine Escoffre-Barbe, Agnès Guerci-Bresler, Michel Tulliez, Stephane Prost, Marc Spentchian, Jean-Michel Cayuela, Josy Reiffers, MD, Jean Claude Chomel, Ali G Turhan, M.D., PhD, Joelle Guilhot, PhD, Francois Guilhot, MD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 381.
https://doi.org/10.1182/blood.V122.21.381.381
Published: 2013
Journal Articles

Targeting STAT5 Expression Resulted in Molecular Response Improvement in Patients with Chronic Phase CML Treated with Imatinib

Philippe Rousselot, MD, PhD, Lydia Roy, MD, Gabriel Etienne, MD, PHD, Laurence Legros, MD, PhD, Aude Charbonnier, MD, PhD, Valérie Coiteux, MD, Pascale Cony-Makhoul, MD, Francois-Xavier Mahon, MD, PhD, Joelle Guilhot, PhD, Jean-Michel Cayuela, Francis Relouzat, Philippe Leboulche, Stephane Prost
Journal: Blood
Blood (2012) 120 (21): 696.
https://doi.org/10.1182/blood.V120.21.696.696
Published: 2012